Organised by International Forum Gastein supported by an unrestricted educational grant from MSD
The objective of this forum is to present and discuss the latest research on how our health systems can address the challenge of multimorbidity, in particular looking at improved patient centeredness and improved health outcomes.
The challenge posed by the rise in prevalence of chronic disease is made even greater by the fact that patients are and will increasingly be suffering from not just one, but several chronic diseases. With the ageing of our population, comorbidities are expected to further rise.
Caring for patients with multimorbidities is particularly resource intensive and is made more difficult as health services usually deal separately with chronic diseases like arthritis, asthma, cancer, COPD, diabetes, mental conditions (Alzheimer, depression) and viral diseases such as Hepatitis C and HIV/AIDS. As a result, this patient group absorbs a considerable part of public budgets for healthcare, social care, long-term care and various community services.
We will discuss: concrete examples and case studies from countries; the epidemilogy and economics of multimorbidity; measuring health system performance vis-a-vis multimorbidity; implementing selfmanagement; poly-pharmacy; and optimised care pathways. This is is the third installment of a series of EHFG sessions on health system performance.
In this session we will start with front loading essential facts and key trends of co-morbidity across Europe. What are the major co-morbidities? Who is affected? How many patients are affected and at what age? Are there differences between European countries? How are countries reacting? Is the challenge proportional to the ageing of the European population? Are our health data fit for purpose in order to assess and eventually address this situation?
This review of essential facts and trends will be preceded by a keynote on the role of the European Union in its support for Member States improving health system performance. This is high on the agenda of the EU and one of the priorities of DG Health and Food Safety, but is the challenge of co-morbidities factored in?
Martin Seychell, Deputy Director General, DG Health and Food Safety (DG SANTE), European Commission
Rokas Navickas, Vilnius University Hospital, Lithuania; CHRODIS Joint Action Programme
Vesna-Kerstin Petric, Ministry of Health, Slovenia
Andrea Feigl, Harvard T.H. Chan School of Public Health, USA
In this session we will discuss with leading experts what is our performance in adapting our health and social systems to the challenge of multimorbid patients. Are some countries ahead and are there good models health authorities can adapt to their needs?
Tit Albreht, Centre for Health System Analyses, National Institute of Public Health, Slovenia; CANCON Joint Action Programme
Stephan Vandenbroucke, Professor of Health Psychology, Faculty of Psychology and Educational Sciences, Université Catholique de Louvain, Belgium
Francois Schellevis, Head of Research, Netherlands Institute for Health Services Research (NIVEL)
Mariana Dyakova, Consultant in Public Health, University of Warwick, UK
Boris Azaïs, Director Public Policy Europe and Canada, MSD
Mattthias Wismar, Senior Health Policy Analyst, European Observatory on Health Systems and Policies